Read on.....Medcan will facilitate:the import and export of...

Read on.....

Medcan will facilitate:

• the import and export of products under CGB’s arrangements with third parties (includingCannTab Therapeutics Ltd (CannTab)) and Pharmocann Ltd (Pharmocann)) as well as any future products that CGB may want to manufacture or distribute;

• the manufacture of CGB’s products (using either its own facility or the facility of third parties);

• The storage of and growing of CGB’s unique genetics and seed bank; and

• use of a designated area within its facility for a lab for genetic development for CGB, and for

  manufacturing of oil extraction for CGB

  In consideration for these manufacturing, import/export and other services to be provided by Medcan,CGB will pay Medcan’s out of pocket expenses associated with the provision of these services and willin addition issue a total of 18 million CGB shares, through the quarterly issue of 2.25 million shares (in aggregate) to the management of Medcan over a 24-month period.